These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30627560)

  • 1. A Brief Review on the Neuroprotective Mechanisms of Vitexin.
    Lima LKF; Pereira SKS; Junior RDSS; Santos FPDS; Nascimento AS; Feitosa CM; Figuerêdo JS; Cavalcante ADN; Araújo ECDC; Rai M
    Biomed Res Int; 2018; 2018():4785089. PubMed ID: 30627560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights of poly(ADP-ribosylation) in neurodegenerative diseases: A focus on protein phase separation and pathologic aggregation.
    Liu C; Fang Y
    Biochem Pharmacol; 2019 Sep; 167():58-63. PubMed ID: 31034795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.
    Collier TJ; Srivastava KR; Justman C; Grammatopoulous T; Hutter-Paier B; Prokesch M; Havas D; Rochet JC; Liu F; Jock K; de Oliveira P; Stirtz GL; Dettmer U; Sortwell CE; Feany MB; Lansbury P; Lapidus L; Paumier KL
    Neurobiol Dis; 2017 Oct; 106():191-204. PubMed ID: 28711409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting protein aggregation for the treatment of degenerative diseases.
    Eisele YS; Monteiro C; Fearns C; Encalada SE; Wiseman RL; Powers ET; Kelly JW
    Nat Rev Drug Discov; 2015 Nov; 14(11):759-80. PubMed ID: 26338154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal Compounds with Special Reference to Gastrodin as Potential Therapeutic Agents for Microglia Mediated Neuroinflammation.
    Li JJ; Liu SJ; Liu XY; Ling EA
    Curr Med Chem; 2018; 25(42):5958-5974. PubMed ID: 29446722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and neurodegenerative disorders: is there still hope for therapeutic intervention?
    Baune BT
    Curr Opin Psychiatry; 2015 Mar; 28(2):148-54. PubMed ID: 25602246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Neuroprotective Effect of Doxycycline on Neurodegenerative Diseases.
    Santa-Cecília FV; Leite CA; Del-Bel E; Raisman-Vozari R
    Neurotox Res; 2019 May; 35(4):981-986. PubMed ID: 30798507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential roles of natural products in the targeting of proteinopathic neurodegenerative diseases.
    Dash R; Jahan I; Ali MC; Mitra S; Munni YA; Timalsina B; Hannan MA; Moon IS
    Neurochem Int; 2021 May; 145():105011. PubMed ID: 33711400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effects of flavonoids in neurodegenerative disorders.
    Spagnuolo C; Moccia S; Russo GL
    Eur J Med Chem; 2018 Jun; 153():105-115. PubMed ID: 28923363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of vitexin against isoflurane-induced neurotoxicity by targeting the TRPV1 and NR2B signaling pathways.
    Chen L; Zhang B; Shan S; Zhao X
    Mol Med Rep; 2016 Dec; 14(6):5607-5613. PubMed ID: 27878303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia.
    Ułamek-Kozioł M; Czuczwar SJ; Januszewski S; Pluta R
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of vitexin, a flavonoid, on pentylenetetrazole-induced seizure in rats.
    Abbasi E; Nassiri-Asl M; Shafeei M; Sheikhi M
    Chem Biol Drug Des; 2012 Aug; 80(2):274-8. PubMed ID: 22554436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Neuroinflammation Therapeutics: PPARs/LXR as Neuroinflammatory Modulators.
    Bastias-Candia S; Garrido A N; Zolezzi JM; Inestrosa NC
    Curr Pharm Des; 2016; 22(10):1312-23. PubMed ID: 26696410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connection between Systemic Inflammation and Neuroinflammation Underlies Neuroprotective Mechanism of Several Phytochemicals in Neurodegenerative Diseases.
    Wang J; Song Y; Chen Z; Leng SX
    Oxid Med Cell Longev; 2018; 2018():1972714. PubMed ID: 30402203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Proteomic Approach to Uncover Neuroprotective Mechanisms of Oleocanthal against Oxidative Stress.
    Giusti L; Angeloni C; Barbalace MC; Lacerenza S; Ciregia F; Ronci M; Urbani A; Manera C; Digiacomo M; Macchia M; Mazzoni MR; Lucacchini A; Hrelia S
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tunneling nanotubes: A novel pharmacological target for neurodegenerative diseases?
    Wang XT; Sun H; Chen NH; Yuan YH
    Pharmacol Res; 2021 Aug; 170():105541. PubMed ID: 33711434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Layers of structure and function in protein aggregation.
    Tanaka M; Komi Y
    Nat Chem Biol; 2015 Jun; 11(6):373-7. PubMed ID: 25978986
    [No Abstract]   [Full Text] [Related]  

  • 19. PPARs: a new target for neuroprotection.
    Bordet R; Gelé P; Duriez P; Fruchart JC
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):285-7. PubMed ID: 16484630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
    Bourdenx M; Koulakiotis NS; Sanoudou D; Bezard E; Dehay B; Tsarbopoulos A
    Prog Neurobiol; 2017 Aug; 155():171-193. PubMed ID: 26209472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.